GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 13.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,889 shares of the company’s stock after acquiring an additional 6,032 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in GE HealthCare Technologies were worth $3,900,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in GEHC. D1 Capital Partners L.P. acquired a new position in GE HealthCare Technologies during the 3rd quarter worth $268,159,000. Van ECK Associates Corp purchased a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at about $208,513,000. State Street Corp grew its position in shares of GE HealthCare Technologies by 7.8% during the third quarter. State Street Corp now owns 18,615,890 shares of the company’s stock worth $1,747,101,000 after buying an additional 1,347,114 shares in the last quarter. Massachusetts Financial Services Co. MA purchased a new stake in shares of GE HealthCare Technologies during the third quarter worth approximately $93,713,000. Finally, Jennison Associates LLC raised its holdings in GE HealthCare Technologies by 124.5% in the fourth quarter. Jennison Associates LLC now owns 1,709,635 shares of the company’s stock valued at $133,659,000 after acquiring an additional 948,017 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

GEHC has been the subject of several analyst reports. Wells Fargo & Company boosted their price target on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their target price for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $96.00.

GE HealthCare Technologies Trading Down 1.0 %

GEHC opened at $87.64 on Monday. The firm has a market cap of $40.04 billion, a price-to-earnings ratio of 24.08, a price-to-earnings-growth ratio of 2.93 and a beta of 1.15. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.55. The business’s 50 day moving average is $83.34 and its two-hundred day moving average is $85.28. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a $0.035 dividend. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date of this dividend is Tuesday, January 14th. This represents a $0.14 annualized dividend and a yield of 0.16%. GE HealthCare Technologies’s dividend payout ratio is 3.85%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.